DK3459543T3 - Carbamatforbindelse til forebyggelse eller behandling af fibromyalgi - Google Patents

Carbamatforbindelse til forebyggelse eller behandling af fibromyalgi Download PDF

Info

Publication number
DK3459543T3
DK3459543T3 DK17799675.8T DK17799675T DK3459543T3 DK 3459543 T3 DK3459543 T3 DK 3459543T3 DK 17799675 T DK17799675 T DK 17799675T DK 3459543 T3 DK3459543 T3 DK 3459543T3
Authority
DK
Denmark
Prior art keywords
fibromyalgia
prevention
treatment
carbamate compound
carbamate
Prior art date
Application number
DK17799675.8T
Other languages
Danish (da)
English (en)
Inventor
Min Jae Jo
Han Ju Yi
Sun Gwan Hwang
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Application granted granted Critical
Publication of DK3459543T3 publication Critical patent/DK3459543T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK17799675.8T 2016-05-19 2017-05-18 Carbamatforbindelse til forebyggelse eller behandling af fibromyalgi DK3459543T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160061392 2016-05-19
PCT/KR2017/005173 WO2017200318A1 (ko) 2016-05-19 2017-05-18 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Publications (1)

Publication Number Publication Date
DK3459543T3 true DK3459543T3 (da) 2023-02-13

Family

ID=60325216

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17799675.8T DK3459543T3 (da) 2016-05-19 2017-05-18 Carbamatforbindelse til forebyggelse eller behandling af fibromyalgi

Country Status (14)

Country Link
US (1) US10849882B2 (cg-RX-API-DMAC7.html)
EP (1) EP3459543B1 (cg-RX-API-DMAC7.html)
JP (1) JP7071287B2 (cg-RX-API-DMAC7.html)
KR (1) KR102489052B1 (cg-RX-API-DMAC7.html)
CN (1) CN109475529B (cg-RX-API-DMAC7.html)
AU (1) AU2017265839B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018073553A2 (cg-RX-API-DMAC7.html)
CA (1) CA3024286A1 (cg-RX-API-DMAC7.html)
DK (1) DK3459543T3 (cg-RX-API-DMAC7.html)
ES (1) ES2935596T3 (cg-RX-API-DMAC7.html)
MX (1) MX394245B (cg-RX-API-DMAC7.html)
PL (1) PL3459543T3 (cg-RX-API-DMAC7.html)
RU (1) RU2753525C2 (cg-RX-API-DMAC7.html)
WO (1) WO2017200318A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102635941B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
EP3711758B1 (en) 2017-11-14 2024-03-27 SK Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing, alleviating or treating absence seizure or epilepsy showing absence seizure
KR102739580B1 (ko) * 2017-11-14 2024-12-06 에스케이바이오팜 주식회사 후기 나트륨 전류의 증가와 관련된 질환을 예방 또는 치료하기 위한 카바메이트 화합물의 용도
ES3027977T3 (en) * 2017-11-14 2025-06-17 Sk Biopharmaceuticals Co Ltd Use of a carbamate compound to prevent, alleviate or treat visceralgia or pain arising from visceral disease
CA3116195A1 (en) * 2018-10-19 2020-04-23 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy
IL293096A (en) * 2019-11-22 2022-07-01 Sk Biopharmaceuticals Co Ltd Oral pharmaceutical composition comprising carbamate compound and preparation method therefor
IT202300007314A1 (it) 2023-04-14 2024-10-14 Soal Pharma Srl Integratore alimentare per il trattamento della fibromialgia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
US20030069306A1 (en) * 2001-07-16 2003-04-10 Codd Ellen C. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
US7598279B2 (en) 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
MY155662A (en) * 2009-06-22 2015-11-13 Sk Biopharmaceuticals Co Ltd Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
JP5901528B2 (ja) * 2009-11-06 2016-04-13 エスケー バイオファーマスティカルズ カンパニー リミテッド 線維筋痛症候群の治療方法

Also Published As

Publication number Publication date
BR112018073553A2 (pt) 2019-03-19
EP3459543A1 (en) 2019-03-27
CA3024286A1 (en) 2017-11-23
RU2753525C2 (ru) 2021-08-17
MX394245B (es) 2025-03-19
EP3459543A4 (en) 2020-01-15
CN109475529A (zh) 2019-03-15
RU2018144785A3 (cg-RX-API-DMAC7.html) 2020-08-11
ES2935596T3 (es) 2023-03-08
AU2017265839A1 (en) 2018-12-13
KR102489052B1 (ko) 2023-01-16
JP2019516707A (ja) 2019-06-20
CN109475529B (zh) 2022-02-22
EP3459543B1 (en) 2022-12-21
MX2018014080A (es) 2019-04-04
WO2017200318A1 (ko) 2017-11-23
KR20170131242A (ko) 2017-11-29
AU2017265839B2 (en) 2022-10-27
US10849882B2 (en) 2020-12-01
RU2018144785A (ru) 2020-06-19
PL3459543T3 (pl) 2023-04-11
US20190298694A1 (en) 2019-10-03
JP7071287B2 (ja) 2022-05-18

Similar Documents

Publication Publication Date Title
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3600281T3 (da) Kombinationsbehandling til behandling eller forebyggelse af tumorer
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3349758T3 (da) Fremgangsmåder til behandling af arenaviridae-virusinfektioner
IL264143B (en) Processes for preparing olaparib
DK3503890T3 (da) Anvendelse af pridopidin til behandling af dystonier
DK3285803T3 (da) Fremgangsmåder til behandling eller forebyggelse af migrænehovedpine
DK3125875T3 (da) Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3504187T3 (da) Anvendelse af pridopidin til behandling af funktionel tilbagegang
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3459543T3 (da) Carbamatforbindelse til forebyggelse eller behandling af fibromyalgi
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
HUE055263T2 (hu) 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére
DK3524255T3 (da) Sammensætning til behandling af acne
DK3624796T3 (da) Pyrrolopyridin.anilinforbindelser til behandling af hudlidelse
DK3081263T3 (da) Sammensætninger og redskaber til behandling af glaukom
DK3466934T3 (da) Sulfonamidforbindelser eller salt deraf som ribonukleotidreductase-inhibitorer til behandling af kræft
DK3307299T3 (da) Kombinationssammensætninger til behandling af lidelser krævende fjernelse eller ødelæggelse af uønskede celleformeringer
DK3436074T3 (da) Thiazolidforbindelser til behandling af virale infektioner
DK3324824T3 (da) Fremgangsmåde til behandling af binokulare dysfunktioner
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3261661T3 (da) Menotropin til behandling af infertilitet
DK3717011T5 (da) Fremgangsmåde til behandling eller forebyggelse af iskæmi-reperfusionsskade
DK3551144T3 (da) Apparatur til strålingsbeskyttelse af øjnene